Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime/MM-GBSA calculation
出版年份 2011 全文链接
标题
Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime/MM-GBSA calculation
作者
关键词
-
出版物
JOURNAL OF COMPUTATIONAL CHEMISTRY
Volume 32, Issue 13, Pages 2800-2809
出版商
Wiley
发表日期
2011-06-30
DOI
10.1002/jcc.21859
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Towards Accurate Free Energy Calculations in Ligand Protein-Binding Studies
- (2010) Thomas Steinbrecher et al. CURRENT MEDICINAL CHEMISTRY
- Structure-based quantitative structure-activity relationship studies of checkpoint kinase 1 inhibitors
- (2010) Juan Du et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Chemical space sampling by different scoring functions and crystal structures
- (2010) Natasja Brooijmans et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- DNA Structure and Integrity Checkpoints during the Cell Cycle and Their Role in Drug Targeting and Sensitivity of Tumor Cells to Anticancer Treatment
- (2009) Andrzej Skladanowski et al. CHEMICAL REVIEWS
- Targeting the DNA Damage Response in Cancer
- (2009) Mats Ljungman CHEMICAL REVIEWS
- Targeted scoring functions for virtual screening
- (2009) Markus H.J. Seifert DRUG DISCOVERY TODAY
- Prediction of Potency of Protease Inhibitors Using Free Energy Simulations with Polarizable Quantum Mechanics-Based Ligand Charges and a Hybrid Water Model
- (2009) Debananda Das et al. Journal of Chemical Information and Modeling
- Computations of Standard Binding Free Energies with Molecular Dynamics Simulations
- (2009) Yuqing Deng et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells
- (2009) L. A. Parsels et al. MOLECULAR CANCER THERAPEUTICS
- Towards improving compound selection in structure-based virtual screening
- (2008) Bohdan Waszkowycz DRUG DISCOVERY TODAY
- What has virtual screening ever done for drug discovery?
- (2008) David E Clark Expert Opinion on Drug Discovery
- AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies
- (2008) S. D. Zabludoff et al. MOLECULAR CANCER THERAPEUTICS
- Rebeccamycin Derivatives as Dual DNA-Damaging Agents and Potent Checkpoint Kinase 1 Inhibitors
- (2008) C. Marminon et al. MOLECULAR PHARMACOLOGY
- Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go
- (2007) N Moitessier et al. BRITISH JOURNAL OF PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now